cd147  (Proteintech)

Journal: Frontiers in Immunology

Article Title: Increased expression of CD36 and CD163 in clear cell renal cell carcinoma suggests an association between lipid transport and an “M2-like” macrophage phenotype

doi: 10.3389/fimmu.2026.1773666

Figure Lengend Snippet: Expression of CD147 in ccRCC samples. (A) CD147 was assessed using immunohistochemistry. Student’s t-test, *p<0.05. (B) Expression of CD147 was assessed using the available TCGA data (KIRC dataset). (C) Correlations of CD147 expression to CD36 and CD163 using area staining intensity. (D) Correlations of CD147 expression to CD36 and CD163 using observer-based histological scores. As these scores are ordinal, individual data points may overlap in scatter plots. The number of overlapping values is indicated by numbers in parentheses. Correlation statistics were performed using Pearson´s correlation coefficients, and p-values were two-tailed. (E) Flow cytometric analysis of CD147 on CD45neg cells from central and peripheral ccRCC tumor tissue and adjacent kidney. Values were normalized to kidney controls. Representative histogram with geometric mean fluorescence intensities on the right. (F) As in (E) , correlations of CD147 expression on CD45neg cells to CD36 in tumor periphery and tumor center. (G) Multiplex immunofluorescence imaging of ccRCC tumor tissues (representative of three patients) depicting CD36 and CD147 expression. White bar represents 200 µm (left) and 10 µm (right). (H) UMAP depicting clusters of single-cell data from ccRCC patients showing the expression of CD147. Cell type annotations were adopted from the original publication . (I) . Flow cytometric analysis of CD147 on CD68+ cells from central and peripheral ccRCC tumor tissue and adjacent kidney. Values were normalized to kidney controls. Representative histogram with geometric mean fluorescence intensities on the right. (J) As in (I) , correlation of CD163 and CD147 expression on CD68+ cells. Pearson´s correlation, two-tailed p-value. (K) UMAP visualization of CD163 and BSG (CD147) expression on myeloid cells from ccRCC tumors, cell type annotations were adopted from the original publication .

Article Snippet: Reagents and antibodies used included FcR Blocking Reagent (Cat# 130-059-901), CD36 PE (Cat# 130-110-877), CD147 APC (Cat# 130-124-295), CD8a PE (Cat# 130-117-201), CD45 PE (Cat# 130-113-118), CD68 PE (Cat# 130-128-345), CD163 PE (Cat# 130-127-908), and pan-Cytokeratin APC (Cat# 130-123-091), all from Miltenyi Biotec.

Techniques: Expressing, Immunohistochemistry, Staining, Two Tailed Test, Fluorescence, Multiplex Assay, Immunofluorescence, Imaging, Single Cell

Journal: Frontiers in Immunology

Article Title: Increased expression of CD36 and CD163 in clear cell renal cell carcinoma suggests an association between lipid transport and an “M2-like” macrophage phenotype

doi: 10.3389/fimmu.2026.1773666

Figure Lengend Snippet: Single cell RNA seq of ccRCC tumors. Data by Bi et al. was visualized and via the Single Cell Portal . Cell types, including immune subpopulations, were annotated as defined by the original authors. Expression of metabolic (ACAA2, SQLE, ACSL3, CD36) and immunologic (CD68, CD163, CD147) genes was examined across these distinct immune compartments. For the characterization of the immune cell populations, please refer to Bi et al. .

Article Snippet: Reagents and antibodies used included FcR Blocking Reagent (Cat# 130-059-901), CD36 PE (Cat# 130-110-877), CD147 APC (Cat# 130-124-295), CD8a PE (Cat# 130-117-201), CD45 PE (Cat# 130-113-118), CD68 PE (Cat# 130-128-345), CD163 PE (Cat# 130-127-908), and pan-Cytokeratin APC (Cat# 130-123-091), all from Miltenyi Biotec.

Techniques: Single Cell, RNA Sequencing, Expressing